Stay updated on MERIT Clinical Trial
Sign up to get notified when there's something new on the MERIT Clinical Trial page.

Latest updates to the MERIT Clinical Trial page
- CheckyesterdayChange DetectedThe clinical trial record is available with details on the completed Phase 3 mepolizumab study, its participants, treatment arms, and measured outcomes. It also includes study documents and information about sharing individual participant data.SummaryDifference62%

- Check8 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedAn NIH notice announces a transition update and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision label advances from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check28 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study record is replaced by a 403 Forbidden message, with a link back to Home.SummaryDifference0.5%

Stay in the know with updates to MERIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MERIT Clinical Trial page.